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The presence of metastatic lymph nodes is a relevant prognostic factor in oral cancer.
Objective: This paper aims to assess metastatic lymph node density (pN+) in patients with tongue 
and floor-of-mouth squamous cell carcinoma (SCC) and the association of this parameter with 
disease-free survival (DFS).
Materials and Methods: A group of 182 patients seen between 1985 and 2007 was included, 169 of 
which were males. Five were on stage I, 35 on stage II, 56 on stage III, and 85 on stage IV. Median 
values were considered in lymph node density assessment, and the Kaplan-Meier curve was used 
to evaluate DFS; survival differences within the group were elicited through the log-rank test.
Results: An average 3.2 metastatic lymph nodes were excised from the patients in the group. Density 
ranged from 0.009 to 0.4, with a mean value of 0.09. Five-year DFS rates were of 44% and 28% for 
the groups with lymph node densities below and above the median respectively (p = 0.006). Two-
year local/regional control was achieved for 71% and 49% for the patients below and above the 
median density respectively (p = 0.01). In terms of pN staging, local/ regional control was achieved 
in 70% and 54% of pN1 and pN2 patients respectively, albeit without statistical significance (0.20%).
Conclusion: Lymph node density may be used as a prognostic indicator for tongue and floor-of-
mouth SCC.
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INTRODUCTION
Neck clearance is a standard procedure used to 
stage and treat regional metastases of upper respira-
tory and digestive tract malignant tumors. Metastatic 
lymph nodes are among the most relevant findings in 
diagnosing advanced disease (stages III and IV). The 
TNM staging system is the main prognostic indicator 
in use today, but recent studies have pointed out 
that lymph node density allows for better prognostic 
accuracy in pN+ patients1,2.
This study looks into lymph node density in 
tongue and floor-of-mouth epidermoid carcinoma 
patients while considering local/regional control 
and survival.
MATERIALS AND METHODS
This study was approved by our institution’s 
Research Ethics Committee and granted permit 
071/2000.
This study was based on reviews performed 
on the charts of tongue and floor-of-mouth epider-
moid carcinoma patients submitted to neck clearance 
between January of 1985 and December of 2007. A 
group of 182 patients with lymph node metastases 
confirmed by histopathology and staged as pN1 and 
pN2 was selected from a larger set of 440 patients. 
One hundred and sixty-nine were males and 13 were 
females, with a mean age of 52 years (27-78). All 
patients were diagnosed with epidermoid carcinoma; 
77 had primary tongue tumors, 98 had floor of mou-
th tumors, and 6 had both sites involved. Five were 
diagnosed as having stage I tumors, 35 had stage II 
disease, 56 were on stage III, 85 on stage IV, and one 
patient could not be re-staged. Neck clearance was 
performed electively in 64 cases and with therapeutic 
purposes in 118 patients. Unilateral neck clearance 
was done in 112 patients and bilateral clearance was 
performed in 70 cases; 181 of the 252 clearance pro-
cedures were of the radical type and 71 were selec-
tive. Lymph nodes were individualized immediately 
after the procedure by one of the team’s surgeons 
and sent to the pathologist for further examination.
Lymph node density was calculated by dividing 
the number of metastatic tumors by the total number 
of removed lymph nodes regardless of the type of cle-
arance procedure. The median value for lymph node 
density was used to divide patients into two groups. 
Local/regional control and disease-free survival were 
analyzed using the Kaplan-Meier estimator and the di-
fferences between both groups were assessed through 
the log-rank test. Differences with an alpha error under 
5% were considered significant.
RESULTS
Patients had a mean 3.2 (1-12) involved lymph 
nodes; 42 (7-140) lymph nodes were removed on 
average per patient. Density ranged between 0.009 
to 0.4 with a mean value of 0.09 and a median value 
of 0.06 (Figure 1).
Figure 1. Lymph node density in accordance with pN staging.
Fifty-seven patients had either local, isolated, 
or associated recurring tumors. Regional recurrence 
was seen in 32 cases; 16 were related to the primary 
tumor site and 10 were isolated recurring tumors. 
Sixteen patients were diagnosed with a second 
primary tumor. Distant recurring tumors were seen 
in 14 cases; isolated recurring tumors were seen in 
only 8 patients.
Five-year DFS was observed in 44% and 28% 
of the patients below and above the median value 
respectively (p = 0.006 - Figure 2). Two-year local/
regional control was seen in 71% and 49% of the pa-
tients below and above the median value respectively 
(p = 0.01 - Figure 3). Local/regional control was seen 
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node density, number of removed lymph nodes and 
metastatic nodes seen in this study are consistent with 
other previously published series, thus indicating the 
similarity in the procedures carried out at various 
centers and in the manifestation of this disease in 
different populations.
The standard approach for oral epidermoid car-
cinoma patients is resecting the primary tumor with 
the proper safety margins to ensure good local control 
and performing neck clearance for the purposes of 
achieving good regional control. Radiotherapy and 
chemotherapy have been used in patients with later 
stage tumors. Adjuvant therapy may introduce toxi-
Figure 3. Local/regional control based on lymph node density.
Figure 4. Local/regional control based on pN staging.
Figure 5. Local/regional control based on median lymph node density 
at the various pN stages.
in 70% and 54% of pN1 and pN2 patients respecti-
vely, but failed to achieve statistical significance (p 
= 0.20 - Figure 4).
Figure 2. Disease-free survival for patients with lymph node density 
below and above the median.
Median lymph node density was 0.03 on pN1 
patients and 0.09 on pN2 patients. No significant 
difference was observed between patients above or 
below the median in regards to pN staging and local/
regional control (Figure 5).
DISCUSSION
Although neck clearance is a standard proce-
dure, the number of retrieved lymph nodes varies 
dramatically in individual basis. The figures on lymph 
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city and severe side effects. A significant challenge, 
therefore, lies in finding a reliable method to stage 
patients for risk of tumor relapse immediately after 
surgery3. Analysis of failure patterns in oral cancer 
patients reveal that approximately 33% of such cases 
occur due to regional metastases. One of the most 
significant prognostic factors in this population is 
the presence of neck metastasis4. The TNM staging 
system uses the number, side, and laterality of posi-
tive lymph nodes to categorize the severity of lymph 
node disease.
Some authors claim that the number of remo-
ved lymph nodes carries prognostic value in pN0 
patients, to suggest a more accurate staging or a 
more responsive immune system5-9. The presence of 
metastatic lymph nodes is one of the most significant 
prognostic indicators in malignant had and neck 
tumors. Lymph node metastasis lead to a reduction 
of approximately 50% on survival, and prognosis is 
significantly worse when three or more metastatic 
lymph nodes are found10,11.
The length of the neck clearance procedure, 
the surgical approach, and the level of histopatho-
logical investigation determine the degree to which 
lymph nodes are examined for metastasis detection 
and, thus, the likelihood of finding metastases in the 
lymph nodes at risk6. Thus, it is expected that these 
factors determine the pN lymph node stage (negative 
or positive).
Lymph node density (number of positive lymph 
nodes divided by the total number of excised lymph 
nodes) has recently emerged as an alternate staging 
system to predict survival after surgery in bladder and 
esophageal carcinoma patients. In such system, the 
ratio of positive lymph nodes in relation to the total 
number of excised lymph nodes was deemed better 
than the TNM staging system to predict survival. Just 
as neck clearance may lead to a better understanding 
of the severity of lymph node disease, lymph node 
density tries to compensate for this factor as it retrie-
ves two bits of information: extent of neck involve-
ment (number of positive lymph nodes) and extent 
of surgical eradication of such lymph nodes (total 
number of lymph nodes removed during surgery)1.
Lymph node density, in the established cut-off 
point, allowed the identification of a group of patients 
that encompasses most pN1 patients and a few pN2 
patients in whom the disease has been controlled 
more effectively. Lymph node density is a quantita-
tive variable, and does not appear to have any direct 
association with disease aggressiveness. However, it 
allows for better discrimination of pN+ patients with 
a more favorable prognosis who may not require 
adjuvant treatment. A density of 0.06 accounts for 
patients with at least 17 lymph nodes dissected for 
each metastatic lymph node, thus reflecting a more 
accurate staging system given the larger sample of 
resected lymph nodes.
It has been postulated that lymph node density 
may have significant prognostic value as it takes three 
factors into account: tumor (number of positive lymph 
nodes), therapy (number of lymph nodes removed 
in the neck clearance procedure), and staging (how 
radical the procedure was in relation to the surgeon 
and the pathologist)1. The detection of small metas-
tatic deposits in lymph nodes may be enhanced with 
sequential cross sections, immunohistochemistry and/
or complementary molecular assays 12.
Survival outcomes in this sample reflect a group 
made up of pN+ patients only, 80% of whom with 
stage IV disease. The main reason for treatment fai-
lure was primary tumor recurrence. Isolated regional 
recurrence was rare.
Metastatic lymph nodes and lymph node den-
sity also reveal a phenotype of systemic disease and 
aggressive involvement in the primary tumor site. 
Lymph node density may be used as a prognostic 
indicator in tongue and floor-of-mouth carcinoma 
patients, as it is better than pN staging for pN1 and 
pN2 patients.
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